In a discovery that could guide the development of next-generation antidepressants and antipsychotic medications, researchers ...

With Black women and straight men increasingly at risk, Gilead’s Yeztugo may finally offer a discreet, stigma-free way to ...

The device stimulates the vagus nerve, signaling the body to tamp down the inflammation that contributes to the disease.

Please provide your email address to receive an email when new articles are posted on . “In the future, with these drug delivery products, [patients] are going to have really extended benefit ...

President Donald Trump's proposed budget cuts to the National Institutes of Health would eventually result in fewer drugs on the market, the U.S. Congressional Budget Office said on Friday.

‘Three-Parent’ Human Experiment Becomes the Standard for a New IVF Treatment Eight children born from three parents are seen as a success despite risks. by Madison Fossa July 18, 2025, 10:10 PM ...

Potential NIH and FDA cuts could lower the number of new drugs that come to market in the next three decades, according to a CBO analysis.

The FDA’s orphan drug designation is granted to drugs and biologics intended for the treatment, diagnosis, or prevention of rare diseases affecting fewer than 200,000 people in the United States. The ...

The regulator had asked Sarepta Therapeutics to halt all shipments of its therapy, Elevidys, after three patients died from liver failure after taking it or a similar treatment.

A new treatment for advanced melanoma is showing promising results for people whose tumors have stopped responding to existing therapies.

The increase in new drug application review times would raise the cost to develop new drugs, the budget office found, and this increase would grow over time and result in a 2% reduction in new ...

FDA grants orphan drug designation to ICT01, a promising immunotherapy for acute myeloid leukemia, targeting unmet needs in older patients.